| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690548 | Urology | 2017 | 24 Pages |
Abstract
High mRNA levels of TOP2A, HELLS, ATAD2, and TET3 are independent predictors of poor outcome in RCC patients and may be used for individual risk-adapted therapy in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Dong Chen, Matthias Maruschke, Oliver Hakenberg, Wolfgang Zimmermann, Christian G. Stief, Alexander Buchner,